• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Diabetes clinic taps DarioHealth for blood glucose monitoring tech

February 13, 2018 By Sarah Faulkner

Dario HealthDarioHealth (NSDQ:DRIO) has partnered with the Diabetes and Endocrinology Consultants of Pennsylvania to bring its blood glucose monitoring system to the 5,000-patient facility.

The company’s blood glucose monitor, which syncs with Dario’s diabetes management app, connects via a headphone jack to a mobile device, helping diabetes patients monitor their blood glucose throughout the day. The app also records carbohydrate intake, insulin use and physical activity.

“When I showed my patients how to use Dario, they immediately got it and I realized that this was going to be a game-changing device,” Dr. Alan Shorr said in prepared remarks.

“The Dario system provides patients with a platform to control their blood sugars in an easy and concise manner. The patient’s sugars and essential data is easy to understand, and patients are coming to the office more informed. My team is able to interpret the data and teach our patients to improve their control of diabetes. This is done in part because Dario simplifies the complexity of diabetes treatment and improves the quality of life for my patients. The device is easy to maintain and does not require carrying multiple items, which is a major plus.”

“We are excited that Dario technology will help us seamlessly incorporate remote blood glucose monitoring into our daily clinical processes, thereby allowing us to actively identify and manage those patients with diabetes that need our guidance in a timely manner,” Dr. Arvind Cavale added. “We hope to demonstrate with this project that clinicians and technology companies can bring high-value services to the management of chronic illnesses such as diabetes.”

“It’s very encouraging to hear from endocrinologists that people with diabetes can get better care with Dario,” DarioHealth chairman & CEO Erez Raphael said. “This is an important step in DarioHealth’s growth and market penetration as we are planning to reach additional users through key opinion leaders and clinics. Partnering with such clinics will allow us to reach users in a faster and a more efficient manner.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Featured, Hospital Care, Patient Monitoring, Wall Street Beat Tagged With: dariohealth

IN CASE YOU MISSED IT

  • BD stock up on Street-beating preliminary quarterly revenue numbers
  • Locate Bio lands FDA breakthrough nod for bone infection device
  • PerkinElmer to acquire Oxford Immunotec
  • Evonik buys polymers business from Durect Corp.
  • New Croatian notified body designated to European MDR

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS